Comparative Proteomic Phenotyping of Cell Lines and Primary Cells to Assess Preservation of Cell Type-specific Functions

被引:393
作者
Pan, Cuiping [1 ]
Kumar, Chanchal [1 ]
Bohl, Sebastian [2 ]
Klingmueller, Ursula [2 ]
Mann, Matthias [1 ]
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] German Canc Res Ctr, Div Syst Biol Signal Transduct, D-69120 Heidelberg, Germany
关键词
QUANTITATIVE PROTEOMICS; SIGNALING NETWORKS; MICROARRAY DATA; AMINO-ACIDS; EXPRESSION; CANCER; IDENTIFICATION; HEPATOCYTES; SILAC; CYTOCHROME-P450;
D O I
10.1074/mcp.M800258-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Biological experiments are most often performed with immortalized cell lines because they are readily available and can be expanded without limitation. However, cell lines may differ from the in vivo situation in important aspects. Here we introduce a straightforward methodology to compare cell lines to their cognate primary cells and to derive a comparative functional phenotype. We used SILAC (stable isotope labeling by amino acids in cell culture) for quantitative, mass spectrometry-based comparison of the hepatoma cell line Hepa1-6 with primary hepatocytes. The resulting quantitative proteome of 4,063 proteins had an asymmetric distribution, with many proteins down-regulated in the cell line. Bioinformatic analysis of the quantitative proteomics phenotypes revealed that Hepa1-6 cells were deficient in mitochondria, reflecting re-arrangement of metabolic pathways, drastically up-regulate cell cycle-associated functions and largely shut down drug metabolizing enzymes characteristic for the liver. This quantitative knowledge of changes provides an important basis to adapt cell lines to more closely resemble physiological conditions. Molecular & Cellular Proteomics 8:443-450, 2009.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 32 条
[1]   Regulation of drug-metabolizing enzymes and transporters in inflammation [J].
Aitken, AE ;
Richardson, TA ;
Morgan, ET .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :123-149
[2]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[3]   Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics [J].
Blagoev, B ;
Ong, SE ;
Kratchmarova, I ;
Mann, M .
NATURE BIOTECHNOLOGY, 2004, 22 (09) :1139-1145
[4]   Breast cancer cell lines: friend or foe? [J].
Burdall, SE ;
Hanby, AM ;
Lansdown, MRJ ;
Speirs, V .
BREAST CANCER RESEARCH, 2003, 5 (02) :89-95
[5]   The use and analysis of microarray data [J].
Butte, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (12) :951-960
[6]   Is proteomics the new genomics? [J].
Cox, Juergen ;
Mann, Matthias .
CELL, 2007, 130 (03) :395-398
[7]   MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification [J].
Cox, Juergen ;
Mann, Matthias .
NATURE BIOTECHNOLOGY, 2008, 26 (12) :1367-1372
[8]  
DARLINGTON GJ, 1980, JNCI-J NATL CANCER I, V64, P809
[9]   Using GOstats to test gene lists for GO term association [J].
Falcon, S. ;
Gentleman, R. .
BIOINFORMATICS, 2007, 23 (02) :257-258
[10]   Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins [J].
Graumann, Johannes ;
Hubner, Nina C. ;
Kim, Jeong Beom ;
Ko, Kinarm ;
Moser, Markus ;
Kumar, Chanchal ;
Cox, Juergen ;
Schoeler, Hans ;
Mann, Matthias .
MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (04) :672-683